Achilles Therapeutics plc Made Big Gain
Thu, Sep 19, 2024 at 05:32 PM
Achilles Therapeutics plc (ACHL:NASDAQ) jumped higher at $0.94, a gain of 35.7%. On Wed, Sep 18, 2024, ACHL:NASDAQ touched a New 2-Week Intraday Low of $0.69. The stock got featured on our News Catalysts scanner on Thu, Sep 19, 2024 at 09:38 AM in the 'MISCELLANEOUS' category. From Thu, Sep 05, 2024, the stock recorded 44.44% Up Days and 30.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Achilles Therapeutics plc (ACHL:NASDAQ)
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens.
Top 10 Gainers:
- Signing Day Sports Inc. (SGN:NYSEMKT), 308.01%
- Garden Stage Limited (GSIW:NASDAQ), 248%
- Zeo Energy Corp Cl A (ZEO:NASDAQ), 122.22%
- Translate Bio, Inc. (TBIO:NASDAQ), 117.04%
- Neo-Concept International Group Holdings Limited (NCI:NASDAQ), 71.6%
- Venus Concept Inc. (VERO:NASDAQ), 71.14%
- Edgewise Therapeutics Inc. (EWTX:NASDAQ), 54.69%
- Rezolve AI Limited (RZLV:NASDAQ), 47.37%
- Achilles Therapeutics plc (ACHL:NASDAQ), 35.74%
- Flora Growth Corp. (FLGC:NASDAQ), 35.24%